CVS Health Corporation
CVS
$66.97
-$0.88-1.30%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.28B | 4.61B | 5.02B | 7.19B | 7.32B |
| Total Depreciation and Amortization | 4.61B | 4.60B | 4.58B | 4.55B | 4.50B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 52.00M | -213.00M | 552.00M | 226.00M | 368.00M |
| Change in Net Operating Assets | -1.19B | 109.00M | -5.54B | -3.89B | -1.30B |
| Cash from Operations | 8.76B | 9.11B | 4.61B | 8.07B | 10.89B |
| Capital Expenditure | -2.82B | -2.78B | -2.92B | -2.80B | -2.75B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -90.00M | -95.00M | -205.00M | -211.00M | -9.54B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.37B | -4.74B | -5.18B | -2.72B | -2.17B |
| Cash from Investing | -6.28B | -7.61B | -8.31B | -5.73B | -14.47B |
| Total Debt Issued | 7.31B | 9.83B | 5.76B | 4.16B | 12.67B |
| Total Debt Repaid | -6.36B | -4.77B | -2.14B | -1.62B | -7.82B |
| Issuance of Common Stock | 302.00M | 361.00M | 377.00M | 385.00M | 384.00M |
| Repurchase of Common Stock | -161.00M | -3.21B | -3.21B | -3.21B | -3.20B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.37B | -3.37B | -3.31B | -3.26B | -3.19B |
| Other Financing Activities | 36.00M | 26.00M | -13.00M | -110.00M | -106.00M |
| Cash from Financing | -2.24B | -1.14B | -2.54B | -3.65B | -1.27B |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 239.00M | 359.00M | -6.24B | -1.31B | -4.85B |